AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing
Leading Diagnostic Healthcare Company Announces Provisional Patent Filing on Proprietary Use of Materials for Ophthalmological…
Year: 2023
Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board
Professor Kranzler is the Benjamin Rush Professor of Psychiatry and Director of the Center for…
Roche Annual General Meeting 2023
All proposals of the Board of Directors approved Severin Schwan elected as new Chairman of…
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
Presentation with live webcast today, March 14th at 10:40 AM ET DURHAM, N.C., March 14,…
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
MODIIN, Israel and NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT)…
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 14, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
World Orphan Drug Alliance Expands to China, Israel, and Greece, Cyprus, and Malta
Greater China region, Israel, and Greece, Cyprus and Malta are now also covered by the…
BioVie Announces Registration Details for “BioVie Day” Webinar
Virtual Webinar to be held March 23, 2023, at 10:00am Eastern Time CARSON CITY, Nev.,…
Gradalis Announces Publication in Clinical Cancer Research Featuring Positive Results from a Study Evaluating Vigil® in Combination Therapy for Patients with Recurrent Ewing’s Sarcoma
-Pilot study in Ewing’s Sarcoma supports the therapeutic potential of Vigil in multiple solid tumor…
Immutep Announces Initiation of Phase II/III Trial for Eftilagimod Alpha plus Paclitaxel in Metastatic Breast Cancer
Media Release Integrated Phase II/III trial design incorporates feedback from the FDA and EMA and…
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
Initiation of APEX Part 2 planned for mid-2023 Updated clinical data from Phase 3 PEAK…
Culture Biosciences Focuses Technology and Service Platform on Biologics
Intelligent upstream bioprocess development for therapeutics using an integrated platform of cloud-based software, single-use bioreactors,…
Proteovant Therapeutics to Present Preclinical Data from Estrogen Receptor and IKZF2 Protein Degrader Programs
PVTX-321 and PVTX-405 Achieve Development Candidate Nomination NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) —…
RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results
Company maintains strong cash position of $249.1 million SOUTH SAN FRANCISCO, Calif., March 14, 2023…
Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter
Shockwave L⁶ Provides Physicians with Larger-Diameter Catheters to Expand Potential Treatment of Peripheral Vessels SANTA…
Novan Announces $6.0 Million Registered Direct Offering
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
EMulate Therapeutics Announces the Addition of Donna Morgan Murray, Ph.D., to its Board of Directors
BELLEVUE, Wash., March 14, 2023 (GLOBE NEWSWIRE) — EMulate Therapeutics, Inc. (“EMulate” or the “Company”)…
LSL Group Closes a Complementary and Final Private Placement of $145,000.10 to Its Reverse Takeover
BOUCHERVILLE, Quebec, March 14, 2023 (GLOBE NEWSWIRE) — LSL PHARMA GROUP INC. (TSXV : LSL)…
MedAvail Announces Closing of $16 Million Private Placement
PHOENIX, March 14, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative…